1.Rectus abdominis endometriosis without previous surgery: A case report.
Espina-Tan CHARISSE ; Ouano Christine Joy O.
Philippine Journal of Obstetrics and Gynecology 2010;34(2):76-81
Endometriosis is a benign condition in which endometrial glands and stroma are present outside the uterine cavity. The most common sites are the ovaries. Abdominal wall implantation, although uncommon, typically occurs in areas of previous surgical scars, usually involving the subcutaneous tissue. Endometriosis arising in the rectus abdominis muscle is rare. A case of extra pelvic endometriosis, spontaneously arising within the rectus abdominis muscle, in the absence of a previous surgical scar, is presented here.
Human ; Female ; Middle Aged ; Rectus Abdominis ; Endometriosis ; Abdominal Wall ; Cicatrix ; Subcutaneous Tissue ; Ovary ; Endometrium ; Subcutaneous Fat ; Uterus ; Vulva
2.Ten Years of Successful Collaboration between Psychiatrists, a Mental Health Institution and General Practitioners in Primary Care
Lum Wai Mun Alvin ; Christine Tan ; Joshua Wee
The Singapore Family Physician 2013;39(1):19-21
This paper gives an overview of what the GP Partnership Programme (GPPP), an integrated care programme, has achieved over a span of ten years, since its implementation in 2003 by the Institute of Mental Health, a tertiary mental health institution in Singapore. The GPPP is a collaboration between the GPs and IMH, for the care and management of stable patients with mental illness in the community and primary care setting. Since 2003, more than 1300 patients have been referred through the GPPP to a team of 51 GP-Partners for continued care within the community.
3.Antibiotic therapy and clinical outcomes of Pseudomonas aeruginosa (PA) bacteraemia.
Sock Hoon TAN ; Christine B TENG ; Tat Ming NG ; David C B LYE
Annals of the Academy of Medicine, Singapore 2014;43(11):526-534
INTRODUCTIONPseudomonas aeruginosa (PA) bacteraemia is associated with high morbidity and mortality. We assessed clinical outcomes in patients with PA bacteraemia treated with piperacillin-tazobactam (TZP) versus other antibiotics, and monotherapy versus combination, all with proven activity by disc testing without minimum inhibitory concentration (MIC) data.
MATERIALS AND METHODSAll patients with PA bacteraemia in 2007 to 2008 were reviewed for demographic, comorbidity, clinical, laboratory, treatment and outcome data. Primary outcome was 30-day mortality. Secondary outcomes included microbiological clearance, clinical response and length of stay (LOS).
RESULTSMedian age for 91 patients was 65 years. Median Simplified Acute Physiology Score (SAPS) II score was 30. Monotherapy was used in 77 cases: 42 on ceftazidime, 17 on TZP, 10 on carbapenems, and 8 on other antipseudomonal antibiotics. The 30-day mortality was 20.9%, and similar between ceftazidime and TZP versus other antibiotics respectively. More patients in combination versus monotherapy group had cardiovascular diseases, diabetes mellitus and vascular access as source of bacteraemia. Patients on monotherapy had higher 30-day mortality (24.7% vs 0%, P = 0.037). Multivariate analysis identified SAPS II score (OR = 1.097, 95% CI, 1.032 to 1.166, P = 0.003) and cancer (OR = 4.873, 95% CI, 1.235 to 19.223, P = 0.024) as independent predictors of 30-day mortality.
CONCLUSIONTZP appeared to be an effective culture-guided antibiotic for PA bacteraemia. High 30-day mortality in monotherapy might be confounded by comorbidity, illness severity and sample size. Cancer patients and a high SAPS II score were independent predictors of 30-day mortality.
Aged ; Anti-Bacterial Agents ; therapeutic use ; Bacteremia ; drug therapy ; Ceftazidime ; therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Penicillanic Acid ; analogs & derivatives ; therapeutic use ; Piperacillin ; therapeutic use ; Pseudomonas Infections ; drug therapy ; Pseudomonas aeruginosa ; Retrospective Studies ; Treatment Outcome
4.Successful preimplantation genetic diagnosis of Hb Bart's hydrops fetalis in Singapore after fresh and frozen embryo replacement cycles.
Christine YAP ; Wen WANG ; Arnold S C TAN ; Wei Chin TAN ; Mui Nee LIM ; Samuel S CHONG
Annals of the Academy of Medicine, Singapore 2009;38(10):910-913
INTRODUCTIONWe report the fi rst successful preimplantation genetic diagnosis (PGD) for Hb Bart's hydrops fetalis in Singapore, involving both fresh and frozen embryo replacement cycles.
CLINICAL PICTURETwo couples who were carriers of the Southeast Asian type double gene deletion (--(SEA) deletion carriers) requested for PGD. Couple A had 2 previous affected pregnancies, while couple B have a child of unknown genotypic status.
TREATMENTOne PGD cycle was performed for each couple. The --(SEA) deletion was detected using a gap-PCR strategy. Couple A had 1 fresh-embryo replacement cycle while couple B underwent 2 frozen-embryo replacement cycles.
OUTCOMECouple A achieved a twin pregnancy. Second trimester complications resulted in premature delivery, where 1 baby girl survived. Couple B achieved a singleton pregnancy resulting in delivery of a healthy baby boy. Genotype analysis of all babies confirmed the PGD results consistent with clinically unaffected status.
CONCLUSIONSWe have successfully performed PGD to avoid Hb Bart's hydrops fetalis syndrome.
Adult ; Embryo Transfer ; Female ; Genetic Carrier Screening ; Genetic Testing ; Hemoglobins, Abnormal ; Humans ; Hydrops Fetalis ; diagnosis ; genetics ; prevention & control ; Male ; Minisatellite Repeats ; genetics ; Ovulation Induction ; methods ; Polymerase Chain Reaction ; Pregnancy ; Pregnancy Complications, Hematologic ; diagnosis ; genetics ; prevention & control ; Preimplantation Diagnosis ; Singapore ; Sperm Injections, Intracytoplasmic ; alpha-Globins ; genetics
5.The use of traditional Chinese medicine among breast cancer patients: implications for the clinician.
Kar Yong WONG ; Ern Yu TAN ; Juliana J C CHEN ; Christine TEO ; Patrick M Y CHAN
Annals of the Academy of Medicine, Singapore 2014;43(2):74-78
INTRODUCTIONTraditional Chinese Medicine or Traditional Complementary Medicine (TCM) is commonly used in our culture. There are several concerns regarding its use in patients undergoing conventional treatments for breast cancer. In this study, we aimed to evaluate the prevalence and pattern of TCM use among our breast cancer patients, and to identify patients who were most likely to choose TCM.
MATERIALS AND METHODSA total of 300 patients on active follow-up with Breast Service at Tan Tock Seng Hospital were interviewed using a structured questionnaire.
RESULTSA total of 35% (104 of 296) of patients reported using TCM. The majority of the patients were introduced to TCM by family and friends following the diagnosis of breast cancer. All except 3 patients continued with recommended conventional therapy although most did not inform their clinicians of TCM use. None of the patients reported any serious adverse events and 75% of them perceived a benefit from TCM use. Younger patients and those of Chinese ethnicity were more likely to use TCM (P <0.01 and P = 0.03 respectively). There was no significant difference in the dialect group, religious beliefs and educational level between the 2 groups (P >0.05).
CONCLUSIONTCM use is common among our breast cancer patients, particularly the younger women. However, most patients do not inform their clinicians of TCM use while on recommended conventional therapies. It is therefore important for clinicians to initiate discussions regarding TCM use in order to be aware of potential unwanted drug interactions.
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms ; therapy ; Female ; Humans ; Medical Oncology ; Medicine, Chinese Traditional ; utilization ; Middle Aged
6.First successful preimplantation genetic diagnosis in Singapore--avoidance of beta-thalassaemia major.
Christine YAP ; Arnold S C TAN ; Wen WANG ; Mui Nee LIM ; Samuel S CHONG
Annals of the Academy of Medicine, Singapore 2009;38(8):720-723
INTRODUCTIONWe report on the first successful preimplantation genetic diagnosis (PGD) in Singapore.
CLINICAL PICTUREA couple who are beta-thalassaemia carriers and have an affected daughter requested for PGD.
TREATMENTTwo cycles of PGD were performed on the couple. Beta-thalassaemia mutations were detected using a nested PCR and minisequencing strategy, and unaffected embryos were selected for transfer.
OUTCOMEA singleton pregnancy was achieved in the second PGD cycle, resulting in the birth of a healthy baby boy with carrier genotype.
CONCLUSIONSThis case report documents the first successful PGD in Singapore, involving a couple at-risk of transmitting beta-thalassaemia major.
Adult ; Female ; Fertilization in Vitro ; Humans ; Male ; Pregnancy ; Preimplantation Diagnosis ; Risk Factors ; Singapore ; beta-Thalassemia ; diagnosis ; genetics ; prevention & control
7.Potential for Cefazolin as De-escalation Therapy for Klebsiella Pneumoniae Bacteraemia.
Tat Ming NG ; Christine B TENG ; Ee Ling LEW ; Li Min LING ; Brenda ANG ; David C LYE
Annals of the Academy of Medicine, Singapore 2015;44(12):571-574
Adult
;
Aged
;
Aged, 80 and over
;
Anti-Bacterial Agents
;
therapeutic use
;
Bacteremia
;
drug therapy
;
Cefazolin
;
therapeutic use
;
Drug Resistance, Bacterial
;
Female
;
Humans
;
Klebsiella Infections
;
drug therapy
;
Klebsiella pneumoniae
;
Male
;
Microbial Sensitivity Tests
;
Middle Aged
;
Retrospective Studies
;
Young Adult
8.Impact of histopathological profile on disease progression of breast cancer patients during the 1st 1-2 years follow-up: Evidence from the Philippine DOH-Breast Cancer Medicine Access Program.
Semira Marie Christine G. ; Balbuena Joanne Marie L. ; Htur-Javier Vanina ; Sandoval-Tan Jennifer ; Ngelangel Corazon A. ; Guerrero Anna Melissa S ; Rosario Rachel Marie B. ; Mercaida Romeo V.
Acta Medica Philippina 2015;49(2):13-17
INTRODUCTION: Current international consensus confirms that certain histopathologic factors such as tumor morphology, histologic grade and presence of lymphovascular invasion are correlated with prognosis. This retrospective cohort study evaluated the correlation between histopathologic profile and time to disease progression (UP) within the first 1-2 years follow-up of Filipino Stage I-Ill early breast cancer patients.
METHODS: This is a retrospective cohort study which included breast cancer patients enrolled in the Department of Health¬Breast Cancer Medicine Access Program (DOH-BCMAP) at the medical oncology clinics of two tertiary hospitals in Manila. Clinical and histopathologic factors were gathered from patient records, and the patients were grouped according to the modified St. Gallen definition of risk categories for patients with breast cancer. Kaplan-Meier survival analysis determined the average UP as well as progression-free survival (PFS). Multivariate logistic regression determined factors contributing to disease progression.
RESULTS AND CONCLUSION: Of the 326 patients enrolled in this study, 18% showed progression, with a median HP of 14 months. UP was comparable among the low-, intermediate- and high-risk groups. PFS during the 1st 1-2 years follow-up was estimated to be at 78% for the high-risk group, 83% for the intermediate-risk group, and 86% for the low-risk group. During this 1st 1-2 years follow-up, no studied factors of interest were shown to be significantly correlated with outcome among this predominantly intermediate to high risk for recurrence breast cancer patients. Follow-up of this patients up to 5 or more years would define sustained gains from the DOH-BCMAP.
Human ; Male ; Female ; Breast ; Breast Neoplasms ; Consensus ; Neoplasms ; Prognosis ; Medical Oncology
9.Safety and effectiveness of improving carbapenem use via prospective review and feedback in a multidisciplinary antimicrobial stewardship programme.
Christine B TENG ; Tat Ming NG ; Michelle W TAN ; Sock Hoon TAN ; Mindy TAY ; Shu Fang LIM ; Li Min LING ; Brenda S ANG ; David C LYE
Annals of the Academy of Medicine, Singapore 2015;44(1):19-25
INTRODUCTIONAntimicrobial stewardship programmes (ASP) can reduce antibiotic use but patient safety concerns exist. We evaluated the safety of prospective carbapenem review and feedback and its impact on carbapenem use and patient outcomes.
MATERIALS AND METHODSAfter 3 months implementation of our ASP, we compared patients with and without acceptance of ASP recommendations on the use of carbapenems. Primary outcome was 30-day mortality. Secondary outcomes included duration of carbapenem use, length of hospitalisation, clinical response, microbiological clearance, 30-day readmission and mortality at discharge.
RESULTSOf 226 recommendations for 183 patients, 59.3% was accepted. De-escalation, switching to oral antibiotics and antibiotic cessation comprised 72% of recommendations. Patients with acceptance of ASP recommendations had lower 30-day mortality and higher end-of-therapy clinical response despite shorter carbapenem duration (P <0.05). Predictors of 30-day mortality were Pitt bacteraemia score (adjusted odds ratio [aOR] 1.39, 95% confidence interval [CI], 1.11 to 1.74; P = 0.004) and non-acceptance of ASP recommendations (aOR 2.84, 95% CI, 1.21 to 6.64; P = 0.016).
CONCLUSIONOur prospective carbapenem review and feedback mainly comprising of reducing carbapenem use is safe.
Carbapenems ; therapeutic use ; Drug Utilization ; standards ; Feedback ; Guideline Adherence ; statistics & numerical data ; Humans ; Patient Safety ; Pharmaceutical Services ; Treatment Outcome
10.Efficacy and safety of on demand tadalafil in the treatment of East and Southeast Asian men with erectile dysfunction: a randomized double-blind, parallel, placebo-controlled clinical study.
Wai Chun Andrew YIP ; Han-Sun CHIANG ; Jesus Benjamin MENDOZA ; Hui-Meng TAN ; Man-Kay LI ; Wei Christine WANG ; Vladimir KOPERNICKY
Asian Journal of Andrology 2006;8(6):685-692
AIMTo assess the efficacy and safety of tadalafil in comparison to a placebo, when taken on demand for 12 weeks by East/Southeast Asian men with erectile dysfunction (ED).
METHODSThis multicenter, randomized, double-blind, parallel group, placebo-controlled study was conducted at 17 centers across East and Southeast Asia between August 2002 and February 2003. Men more than 18 years of age with mild to severe ED of various etiologies were randomized to receive a placebo or 20 mg of tadalafil taken as needed (maximum once daily). Efficacy assessments included the International Index of Erectile Function, the Sexual Encounter Profile diary and Global Assessment Questions.
RESULTSTadalafil significantly improved erectile function as compared to the placebo (P < 0.001). At the endpoint, the patients receiving 20 mg of tadalafil reported a greater mean per patient percentage of successful intercourse attempts (Sexual Encounter Profile question 3: 70.9% compared to 33.5% in the placebo) and a greater proportion of improved erections (Global Assessment Question: 86.2% compared to 30.1%). Most (= or < 3%) treatment emergent adverse events were mild or moderate. The most common treatment emergent adverse events were headache, back pain, dizziness and dyspepsia.
CONCLUSIONTadalafil was an effective and well-tolerated treatment for ED in East and Southeast Asian men.
Adolescent ; Adult ; Aged ; Asia, Southeastern ; Carbolines ; adverse effects ; therapeutic use ; China ; Double-Blind Method ; Erectile Dysfunction ; drug therapy ; Humans ; Male ; Middle Aged ; Phosphodiesterase Inhibitors ; adverse effects ; therapeutic use ; Tadalafil ; Treatment Outcome